Vogenx, Inc. VOGX
20.77 USD +1.51 (+7.84%)
At closeNov 11, 2026, 4:00 PM EST
20.77 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
17.65 Day range 21.48
12.95 52-week range 38.41
- YTD
- +59.77%
- 1 year
- +59.77%
News
benzinga.com Vogenx Q3 EPS $(0.47) Misses $(0.09) Estimate Vogenx (NASDAQ:VOGX) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.09) by 422.22 percent. This is a 840 percent decrease over losses of $(0.05) per…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Biohaven (NYSE:BHVN) shares increased by 39.3% to $16.37 during Thursday's pre-market session. The company's market cap stands at $1.7 billion. Vogenx (NASDAQ:VOGX) stock rose 22.05% to…
benzinga.com Why QuantumScape Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket QuantumScape rises 9.1% after narrower loss and new solid-state battery production plans; SHFS leads gainers while POM and others fall premarket.
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Tempest Therapeutics (NASDAQ:TPST) stock rose 8.9% to $0.57 during Wednesday's after-market session. The market value of their outstanding shares is at $10.1 million. Tenax Therapeutics…- benzinga.com Vogenx Initiates EMERGE, Phase 2b Clinical Trial Evaluating Mizagliflozin For Treatment Of Post-Bariatric Hypoglycemia Randomized, double-blind, placebo-controlled trial will evaluate two doses of the first-in-class, minimally absorbed SGLT1 inhibitor in patients with recurrent hypoglycemia following bariatric…
accessnewswire.com Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia Randomized, double-blind, placebo-controlled trial will evaluate two doses of the first-in-class, minimally absorbed SGLT1 inhibitor in patients with recurrent hypoglycemia following bariatric…
accessnewswire.com Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer Thirty-year biopharmaceutical commercial leader transitions from the Board of Directors to Chief Commercial Officer Appointment strengthens corporate strategy, business development and commercial…- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Prime Medicine (NASDAQ:PRME) shares increased by 13.0% to $3.47 during Thursday's after-market session. The market value of their outstanding shares is at $567.7 million. Onconetix…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Jaguar Health (NASDAQ:JAGX) stock increased by 304.5% to $10.8 during Tuesday's regular session. The company's market cap stands at $1.1 million. Greenland Mines (NASDAQ:GRML) shares moved…
accessnewswire.com Vogenx Appoints Ken Toombs to Board of Directors Former Chief Executive Officer of PA Consulting brings three decades of global professional services and life sciences leadership experience Appointment broadens independent oversight as the Company…
benzinga.com Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
benzinga.com WBB Securities Initiates Coverage On Vogenx with Speculative Buy Rating, Announces Price Target of $42 WBB Securities analyst Steve Brozak initiates coverage on Vogenx (NASDAQ:VOGX) with a Speculative Buy rating and announces Price Target of $42.- benzinga.com Jones Trading Initiates Coverage On Vogenx with Buy Rating, Announces Price Target of $55 Jones Trading analyst Catherine Novack initiates coverage on Vogenx (NASDAQ:VOGX) with a Buy rating and announces Price Target of $55.
benzinga.com Why Flexsteel Industries Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket Flexsteel Industries Inc (FLXS) reported better-than-expected Q4 results, with shares jumping 9% in pre-market trading. Other gainers include PFSA, EJH, XOS, WETO, SGLY, VOGX, WFF, AMLX, and ENRD.…
prnewswire.com Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering LOS ANGELES and NEW YORK, Aug. 17, 2026 /PRNewswire/ -- JonesTrading Institutional Services LLC ("Jones") today announced that it served as sole book-running manager for the $81.3 million initial…
accessnewswire.com Vogenx Announces Closing of Initial Public Offering RALEIGH, NC / ACCESS Newswire / August 13, 2026 / Vogenx, Inc. (NASDAQ:VOGX) ("Vogenx"), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for…
accessnewswire.com Vogenx Announces Pricing of Initial Public Offering RALEIGH, NC / ACCESS Newswire / August 11, 2026 / Vogenx, Inc. (NASDAQ:VOGX) ("Vogenx"), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for…